Shanehsaz SM, Ishkhanian S. Therapeutic and adverse effects of standard-dose and low-dose meglumine antimoniate during systemic treatment of Syrian cutaneous leishmaniasis patients. J Pak Assoc Dermatol [Internet]. 2016Dec.2 [cited 2026Feb.26];24(2):115-21. Available from: https://www.jpad.com.pk/index.php/jpad/article/view/189